April 2010
Volume 51, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2010
Serial Measurement of Tear Meniscus by Fourier-Domain Optical Coherence Tomography After Instillation of Artificial Tears in Patients With Dry Eyes
Author Affiliations & Notes
  • M. C. Bujak
    Ophthalmology, Doheny Eye Institute/ USC, Los Angeles, California
  • D. Huang
    Ophthalmology, Doheny Eye Institute/ USC, Los Angeles, California
  • S. R. Sadda
    Ophthalmology, Doheny Eye Institute/ USC, Los Angeles, California
  • Y. Li
    Ophthalmology, Doheny Eye Institute/ USC, Los Angeles, California
  • P. Nguyen
    Ophthalmology, Doheny Eye Institute/ USC, Los Angeles, California
  • R. K. Pappuru
    Ophthalmology, Doheny Eye Institute/ USC, Los Angeles, California
  • S. Yiu
    Ophthalmology, Doheny Eye Institute/ USC, Los Angeles, California
  • Footnotes
    Commercial Relationships  M.C. Bujak, None; D. Huang, optovue inc, C; optovue inc, I; optovue inc, carl zeiss meditec inc, P; optovue inc, R; S.R. Sadda, heidelberg engineering, topcon medical systems, carl zeiss meditec, optovue inc, genentech, allergan, C; Y. Li, optovue, C; P. Nguyen, None; R.K. Pappuru, None; S. Yiu, None.
  • Footnotes
    Support  Ro1 EY018184
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 3374. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. C. Bujak, D. Huang, S. R. Sadda, Y. Li, P. Nguyen, R. K. Pappuru, S. Yiu; Serial Measurement of Tear Meniscus by Fourier-Domain Optical Coherence Tomography After Instillation of Artificial Tears in Patients With Dry Eyes. Invest. Ophthalmol. Vis. Sci. 2010;51(13):3374.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To use Fourier-Domain Optical Coherence Tomography to study the longitudinal effect of instillation of artificial tears on tear meniscus volume in patients with dry eyes.

Methods: : Four patients with significant dry eyes were recruited in a consecutive manner from a tertiary cornea practice. The lower tear meniscus of the right eye in each subject was imaged by vertical scans centered on the inferior cornea and the lower eyelid using a Fourier-domain optical coherence tomography system (RTVue; Optovue, Inc., Fremont, CA) with a corneal adaptor. Two baseline measurements were taken for each subject prior to administration of a drop of artificial tears (Optive). Five serial pairs of measurements were then taken after the instillation of artificial tears at 1 minute, 2 minutes, 5 minutes, 10 minutes, and 15 minutes. Each measurement was taken two seconds after a blink. The lower meniscus height, depth, and angle were measured with a computer caliper. The cross-sectional area was calculated using a two-triangle approximation.

Results: : The baseline tear measurements were 317 µm, 512.5 µm, 0.0695 mm2 for meniscus height, depth, and area respectively. At 1 minute after instillation of artificial tears the measurements increased by 212%, 488%, 2212%. The time to depletion of half of the gains in tear meniscus were 2.75 minutes, 4.75 minutes, and 2 minutes for height, depth, area respectively. The time to depletion of 75% of the tear meniscus gains was 3.5 minutes, 5.5 minutes, and 5.5 minutes.

Conclusions: : Optical coherence tomography is able to quantify the increase in lower tear meniscus after installation of artificial tears in patients with dry eyes. This increase is transient, with a 50% reduction of both height and area within 3 minutes of drop instillation and a 75% reduction in all parameters by 6 minutes. Optical coherence tomography may serve as an invaluable tool in objectively quantifying the efficacy of dry eye treatments.

Keywords: cornea: tears/tear film/dry eye • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • imaging/image analysis: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×